Multiple marker detection in peripheral blood for NSCLC diagnosis

Area of Science:

• Oncology
• Molecular Diagnostics
• Biomarker Discovery

Background:

• Early detection of lung cancer is crucial for improving patient prognosis.
• Current diagnostic methods can be invasive or lack sensitivity for early-stage disease.
• Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.

Purpose of the Study:

• To evaluate the diagnostic accuracy of a panel of peripheral blood markers for detecting NSCLC.
• To assess the potential of non-invasive biomarkers for early lung cancer diagnosis.

Main Methods:

• A study involving 100 healthy donors and 100 NSCLC patients.
• Analysis of free circulating DNA and mRNA expression of PADI4, PPBP, and haptoglobin using Real-Time PCR.
• Statistical analysis including logistic regression and ROC curve analysis.

Main Results:

• Significantly higher levels of free circulating DNA, PADI4, PPBP, and haptoglobin were observed in NSCLC patients compared to healthy donors.
• A logistic regression model showed a significant association between marker expression and lung cancer risk.
• A combination of free DNA, PPBP, and PADI4 achieved an area under the ROC curve of 0.93 with over 90% sensitivity and specificity.

Conclusions:

• A non-invasive multimarker approach using free circulating DNA, PPBP, and PADI4 shows high accuracy in discriminating between NSCLC patients and healthy individuals.
• This approach holds promise for the diagnostic or screening workup of suspected lung cancer.
• Further research is warranted to validate its clinical utility.